Hide Board Information

Show Board Information

Easy Technologies Inc EMYSD

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/09/2014 6:01:56 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 5

Easy Technologies Inc (OTCMRKTS: EMYSD) Stock Message Board

1. EMYSD Company Profile

    

2. EMYSD Time & Sales

    

3. EMYSD Recent News

    

4. EMYSD Filings

    

5. EMYSD Financials

    

6. EMYSD Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	Latest Easymed Svcs Inc (EMYSF) Headlines	Stock_Tracker	03/09/2014 6:01:56 PM
6	EMYSF 0.133 Stock Charts $EMYSF 1 Month Chart	chartguy89	03/07/2014 1:52:49 AM
5	EMYSF Stock Charts Last: -0.031 Tuesday, February	chartguy89	02/25/2014 10:44:13 PM
4	EMYSF green this morning! +.0022	Roger Wilco	05/03/2013 10:26:49 AM
3	EMYSF +.046 $.196 EasyMed Services	Roger Wilco	05/01/2013 1:52:09 PM
2	I believe once people see the quality of this	funnymoney50	05/01/2013 11:00:26 AM
1	EMYSF +.105 looking great here.	Roger Wilco	05/01/2013 10:52:14 AM

Recent Articles

• JPMorgan and Bank of America Face Share Price Decline Amid Controversy
• Investigation into BellRing Brands for Potential Fraud
• Pacific Urban Investors Strengthens Portfolio with The Garnett
• Dakota Wealth Introduces DAK ETF for Modern Investors
• Revolutionizing Legal Tech with Practice AI and SmartAdvocate
• Michael Baker International Welcomes New Bridge Operations Lead
• Evaluating Williams Companies Inc: Stock Performance Insights
• Investigation Announced on KBR, Inc. Securities Claims
• Grand Opening of Beacon Rail District: A New Era in Luxury Living
• Experience Hilarity in the Unusual Escape Game Pritto Prisoner
• How New Immigration Policies Will Impact Hospitality Wages
• Introducing DeerRun's Innovative Treadmills for Wellness
• Transforming Portable Sanitation: Trends by Diamond Porta Potty
• GTM Live Event: Elevating Go-To-Market Strategies Together
• Investors Urged to Act: Rocket Pharmaceuticals Faces Legal Heat
• Palantir Technologies Achieves Milestone: What’s Next?
• Understanding Investor Rights After Tungray Technologies Inc's Issues
• Investor Rights Firm Looks Into Shareholder Rights for NASDAQ Stocks
• Cryptocurrency Market Weakens Amidst Economic Indicators
• New York's Freedom Plaza: A Vision for Economic Empowerment
• Beacon Rail District: A New Era of Luxury Apartments
• Harnessing Deregulation for Growth with the Free Markets ETF
• Real Good Foods Implements Share Transfer Initiative for Investors
• StrikeStream Launch: Transforming AI in Security Operations
• Experience California's Wine Crush Season with Peregrine's Getaway
• Reviving Energy Independence: General Matter's Bold Move
• Tricoci University Expands Curriculum with Innovative Head Spa Program
• bioMérieux Unveils Innovative Mold Detection Solution
• Understanding the Implications of Vestis Securities Class Action
• Transforming Urban Landscapes: The Freedom Plaza Initiative
• Tevogen.AI Strengthens Alliance with Microsoft and Databricks
• Michael Novogratz Analyzes Future of Currency Holdings
• General Matter's Historic Push for Domestic Uranium Enrichment
• Ormat Technologies Earnings Forecast: Investor Insights & Analysis
• Sloane Maya Shines on National Television for Baby of the Year
• Tricoci University Launches Exciting New Manicuring Program
• Explore Grant Opportunities for Digital Justice Projects
• Legal Avenues for Investors in Rocket Pharmaceuticals Uncovered
• Understanding the Risks and Legal Aspects of Legionnaires' Disease
• Mel Gordon Takes the Helm as CEO of Chronicle Heritage
• Investigation into Harlem Legionnaires' Disease Outbreak Update
• Sprott Inc. Announces Exciting Dividend for Investors
• Understanding the Recent Class Action Against Lineage, Inc. (LINE)
• Understanding the Investigation Into Agilon Health, Inc. AGL
• Johnson Fistel Probes STAAR Surgical's Potential Merger Deal
• Insights on BellRing Brands, Inc. and Its Market Position
• Roku's Game-Changer: Unveiling a Subscription Streaming Service
• Quantum Biopharma Achieves Key Milestone in MS Drug Trials
• Century Complete Launches New Homes in Nevada's Ishani Ridge
• Understanding Market Sentiment Trends for CareTrust REIT